Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04297605
Title Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Rochester
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab + Pemetrexed Disodium

Nab-paclitaxel + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.